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In previous in v#ro studies, we proposed a role for the extracellular matrix component, lam-
inin-2, and its integrin receptor, VLA-6, in thymocyte development. The characterization of
two dystrophic mouse strains with different defects in laminin-2 allowed us to examine this
proposal in vivo. Mice deficient in laminin-2, dy/dy, show a significant reduction in thymus
size and number of thymocytes compared to normal littermates. These mice also exhibited
apparent alterations of thymic architecture. Examination of the CD4/CD8 populations in dy/dy
thymi showed large relative increases in the DN (CD4-CD8-) and SP (CD4+CD8-,
CD4-CD8+) populations and a significant decrease in the DP (CD4+CD8+) population. Fur-
ther examination of the DN population for CD44 and CD25 expression showed a remarkable
decrease in the more mature pre-T cell populations. Analysis of apoptosis in situ, and by flow
cytometry, in dy/dy thymi revealed a significant increase in apoptotic DN thymocytes in the
capsule and subcapsular regions. Interestingly, thymocyte development appeared to proceed
normally in dystrophic mice expressing a mutant form of laminin-2, dy2J, as well as, in fetal
and neonatal dy/dy mice. We propose that laminin-2 plays an active role in thymocyte devel-
opment by delivering cell survival and differentiation signals at specific stages of develop-
ment in young adult mice.
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INTRODUCTION
The laminins are a family of extracellular matrix
(ECM) proteins found in basement membranes; they
are heterotrimeric proteins consisting of a heavy
chain (c) and two light chains (13, T). Laminin-1 (clas-
sically known as laminin) is composed of the 1, [1
and T1 chains while laminin-2 (merosin) contains the
cz2, [31 and y1 chains (Wewer and Engvall 1994,
Burgeson et al, 1994). Laminin-2 has been shown to
be a ligand for VLA-6 (cZ6l), an integrin which is
expressed on thymocytes (Chang et al, 1993,
Lannes-Vieira et al, 1993). The three component
chains of laminin self-assemble to form the mature
laminin molecule which then polymerizes and repre-
sents a major component of the basal lamina
(Lannes-Vieira et al, 1990). The various laminin iso-
forms are expressed in a tissue or developmental
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stage- specific manner (Leivo and Engvall, 1988,
Ehrig et al, 1990, Wewer et al, 1994).
During thymocyte development, maturation and
selection, the thymocytes migrate through the differ-
ent compartments of the thymus (Sprent et al, 1988,
Scollay and Godfrey, 1995). Each compartment
presents a different microenvironment to the develop-
ing thymocytes and directly affects the differentiation,
proliferation and survival of the cells passing through
it (Ritter and Boyd, 1993). The earliest populations of
thymocytes are CD4-CD8- cells referred to as "double
negative" (DN). This population may be subdivided
into several defined developmental populations by a
variety of markers including CD44 and CD25 (God-
frey et al, 1993, Godfrey et al, 1994). As double nega-
tive cells mature, they acquire CD3, CD4 and CD8
surface expression as they progress to a population
referred to as double positive (CD4+CD8+) (DP). The
double positive cells further mature along either the
CD4 or CD8 pathway to mature single positive cells
(for a review see Guidos, 1996). By the time mature
single positive thymocytes exit the thymus for the
periphery, they will have undergone positive and neg-
ative selection-- processes which delete self-reactive
cells and provide self-MHC-restricted immunocom-
petent effector T cells to the periphery.
Laminin-2 has been shown to be expressed in the
adult mouse thymus exclusive of laminin-1 and cer-
tain immature populations of murine thymocytes
(Jlld+) have been shown to adhere to laminin-2
(Chang et al, 1993). This evidence, together with pre-
vious data (Wadsworth et al, 1993), is suggestive of a
role for laminin-2 in thymocyte development.
Various cells recognize and bind to extracellular
matrix molecules through cell surface receptors of the
integrin family. The numerous heterodimeric integrin
molecules are classified according to the 3 chain
used; each [ chain can associate with between one and
nine different a chains. Thymocytes express several [ 1
integrins (Wadsworth et al, 1993) including the lam-
inin-2 receptor, o6[ 1 (VLA-6). Numerous studies have
examined the functions of the integrins (Hynes, 1992,
Giancotti, 1997, Savino and Silva-Barbosa, 1996,
Malik, 1997) and two groups have produced [ 1 knock-
out mice (Stephens et al, 1995, Fassler and Meyer,
1995). Both of these groups found that disruption of 1
function led to embryonic lethality. The dy (dystrophia
muscularis) mice, in which laminin-2 expression is
undetectable, have provided a "knockout" system with
which to investigate the possible role that laminin-2
may play in T cell ontogeny.
Muscular dystrophy is an autosomal recessive, neu-
romuscular degenerative disease, characterized by
muscle degeneration and dysmyelination in the nerv-
ous system (Duowitz, 1992, Worton, 1995, Mat-
sumura and Campbell, 1993). The mdx and dy mice
are two of the animal models used in the study ofthis
disease (Campbell, 1995). The dystrophin gene was
cloned and found to be deficient in the mdx mouse but
normal in the dy mouse (Hynes, 1992, Worton, 1995,
Xu et al, 1994a). The defect in the homozygous dy
mouse (dy/dy) has been identified as a lack of lam-
inin-2, an anchor protein in basal lamina important for
muscle cell binding. It has been hypothesized that dis-
ruption of the linkage between the subsarcolemmal
cytoskeleton and the basal lamina could result in the
muscle cell necrosis and peripheral neuropathy char-
acteristic of the dy/dy mouse and human muscular
dystrophy patients (Sunada et al, 1994, Xu et al,
1994a, Xu et al, 1994b). The dy2J mouse, which
expresses a form of murine dystrophia muscularis
related to but distinct from the dy strain, was also ana-
lyzed to determine its genetic defect (Xu et al, 1994a,
Sunada et al, 1995). These mice have near normal
levels of laminin-2 expression in their tissues but they
display symptoms comparable to the dy/dy mice. In
the dy2J strain, the laminin o2 chain gene was shown
to carry a mutation identified as a 171 bp in-frame
deletion as well as a splice donor site mutation in the
laminin-2 heavy chain transcript. The expressed form
of the o2 chain in these mice has a 57 amino acid
deletion (residues 34-90) and a substitution (Q91E)
in the N-terminal domain VI (Xu et al, 1994a, Sunada
et al, 1995). These mutations are sufficient to mimic
the muscular dystrophy phenotype of mice lacking
laminin-2 expression.
We have taken advantage of the laminin-2 defi-
ciency in the dy/dy mice to examine the role of lam-
inin-2 in thymocyte development. We show that the
dy/dy thymus is reduced in size out of proportion toLAMININ-2 IN THYMOCYTE DEVELOPMENT 181
the overall diminished size of the animals and that the
thymic architecture is dramatically altered, especially
in the reduction of the cortical regions. This dimin-
ished cortex correlated with a dramatic reduction in
the size of the CD4+CD8+ (DP) population, normally
the largest population in the thymus. The relative size
of the CD4-CD8- population was markedly increased
while the more mature subpopulations within this
subset were reduced in size. The subpopulations that
were relatively reduced in size in the dy/dy mice were
the populations that show the highest affinity for lam-
inin-2. We present a model for the role of laminin-2 in
thymocyte development and immunohistochemical
analyses of dy/dy and dy control thymi to support our
conclusion that a likely cause of these developmental
deficiencies is an abnormal level of apoptotic thymo-
cyte death We believe this death results from the lack
of a differentiation or survival signal that is normally
provided to immature thymocytes by laminin-2.
MATERIALS AND METHODS
Mice
Adult (4-6 week old) C57BL/6J-dy male and female
mice, with control littermates, were obtained from
The Jackson Laboratory, Bar Harbor, ME.
C57BL/6J-dy2J male mice were a generous gift from
Dr. Eva Engvall of The Burnham Institute (La Jolla
Cancer Research Foundation), La Jolla, California.
Homozygous dy/dy mice can not breed; heterozygous
mice were bred and homozygous dy/dy mice selected
from the litters by phenotype. Heterozygous dys-
trophic mice (dy/+) were not distinguished from wild
type (+/+) therefore, control littermates will be
referred to as dy control mice (+/?) throughout this
paper; the homozygous mutant mice are referred to as
dy/dy. The C57BL/6J-dy2J mice used were all
homozygous for the mutation and will simply be
referred to as dy2J.
Antibodies
The antibodies used for FACS analyses anti-CD25
(clone 7D4 labeled with FITC), anti-CD44 (clone
IM7 labeled with PE), anti-CD4 (clone RM-4-5
labeled with PE), anti-CD8 (clone 53-6.7 labeled
with FITC) were purchased from Pharmingen, San
Diego, CA.
The antibodies used for immunofluorescent stain-
ing were anti-laminin clone I (purchased from Life
Technologies Inc., Gaithersburg, MD) and the
anti-medullary epithelia (ERTR5) which was gener-
ously provided by Dr. Willem van Ewijk, Dept. of
Immunology, Erasmus University, Rotterdam, The
Netherlands. Cortical thymic epithelia were stained
with the monoclonal rat anti-mouse antibody (IgM)
clone 4F1 (BioSource International, Camarillo, CA).
The antibodies used in ELISA analyses of ECM
extracts were mouse anti-human laminin-2, which is
known to cross-react with mouse laminin-2 (Chemi-
con International Inc., Temecula, CA), rabbit
anti-mouse fibronectin (Life Technologies, Inc.,
Gaithersburg, MD) and rabbit anti-mouse laminin
(Upstate Biotechnology Inc., Lake Placid, NY).
The antibodies used for immunodepletion were
3.155 anti-CD8 antibody (TIB-211 hybridoma) and
GK1.5 anti-CD4 antibody (TIB-207 hybridoma) from
ATCC, Rockville, MD.
Cells and Tissues
Adult thymocytes were prepared as described (Chang
et al, 1993). Briefly, thymi were gently minced
between two layers of fine mesh nylon screen in
Medium 199 (Life Technologies, Inc., Gaithersburg,
MD) with 0.5% BSA and the cell suspensions were
filtered through nylon to remove debris.
CD4-CD8- thymocytes were prepared by comple-
ment (Cedarlane Laboratories, Ltd., Hornby, Ontario,
Canada) mediated depletion with 3.155 anti-CD8
monoclonal antibody followed by DynaBead (Dynal
Inc., Lake Success, NY) removal of CD4+cells with
GK1.5 monoclonal antibody coated sheep anti-rat
dynabeads according to manufacturers instructions.
Mouse thymus samples were fixed in 10% neutral
phosphate-buffered formalin, embedded in paraffin,
and sectioned at 6gm before staining with hematoxy-
lin-eosin (H&E) by standard methods.182 WILLIAM J. MAGNER et al.
TABLE Analysis of dystrophic mouse mass and cell numbersa’b
thymus wt cells SD cells/mg th.ymus genotype body weight (g) SD thymus weight (mg) SD (mg)/body wt (g) (xl0-6) (]O-U)
dy control 25.9 1.3 42.8 11. 1.7 67.8 23.3 1.6
dy/dy 10.9 1.4 10.6 8.3 1.0 7.5 4.72 0.7
Dystrophic mice with a genetic defect in the expression of laminin-2 were compared to dy control mice on the basis of physical charac-
teristics of thei bodies and thymi; all mice were matched for age and sex. Thymi from dy/dy mice demonstrate a dramatic reduction in thy-
mocyte number.
b. Each value is the average of three determinations.
For immunohistochemical analyses, thymus tissues
were snap-frozen in Tissue-Tek O.C.T. compound
chilled with methylbutane/dry ice. Frozen sections
were prepared with a Tissue-Tek cryostat microtome.
The sections were air-dried, fixed in acetone at-20
C for 10 min, preincubated in 10% normal goat
serum to prevent non-specific binding of antibodies,
and then incubated at 37 C for 60 min with primary
antibodies diluted in 2% goat serum. After washing
with phosphate-buffered saline, species-appropriate
fluorescein-conjugated secondary antibodies were
applied for 45 min. The slides were examined under
an Olympus BH-2 fluorescent microscope. Replace-
ment of primary antibodies with either IgM or IgG
served as a negative control for each antibody. Posi-
tive control sections of normal mouse thymus tissues
were also tested.
Flow Cytometry
Flow cytometric analyses were conducted by standard
methods on a FACSort (Becton Dickinson, San Jose,
CA). Data presented are representative of at least
three independent experiments. Each two-dimen-
sional dot plot represents 10,000 cells analyzed.
Flow cytometric analysis of apoptosis was accom-
plished through use of Beckman-Coulter flow cytoen-
zymology technology. The CellProbe reagents
YVAD-Caspase 1, DEVD-Caspase 3 and VEID-Cas-
pase 6 were generously supplied by Dr. Frank Lucas
of the Coulter Corporation (Miami, Florida). These
reagents incorporate a tetrapeptide substrate specific
to each of the caspase enzymes with a fluorophore C
terminal to the proteolytic cleavage site. The assays
were conducted as described by Coulter; basically,
cells are prepared by standard means for flow cytom-
etry then, 60 minutes prior to analysis, the substrate is
added to the cell suspension. The substrate is freely
permeable to the cell membrane. Flow cytoenzymol-
ogy, simultaneous with typical flow cytometry, was
carried out on a FACS Calibur (Becton Dickinson,
San Jose, CA). Caspase activity was quantitated on
FL 1, surface markers on FL2 and FL4 and propidium
iodide exclusion was monitored on FL3.
Cell Adhesion Assay
Thymocyte binding to ECM proteins was assayed as
described by Shimizu et al. (Shimizu et al, 1990) with
minor modifications. Briefly, aliquots of 100 gl of 10
gg/ml of human laminin-2 or mouse fibronectin in
PBS (containing Ca++ and Mg++) were added to
96-well flat-bottom microtiter plates (Removawell
Strip System, Dynatech Laboratories, Inc., Chantilly,
VA) and incubated at 4 C overnight. After washing
the wells and blocking with 2.5% BSA in PBS for 2-
2.5 h at 37 C, 51Cr-labeled cells (5 x 105/well) were
added in 100 gl of assay medium (Medium 199 with
0.5% BSA). After 45 min at 4 C, plates were rapidly
warmed to 37C for 15 min; nonadherent cells were
removed by gently washing three times with the assay
medium. Wells were then separated and bound radio-
activity was determined by gamma counting. Data are
expressed as the mean percent of cells bound in tripli-
cate wells. Percent cells bound was calculated as
(bound cpm/total cpm added per well) x 100. Back-
ground binding to BSA-coated wells was 1-2% and
was not subtracted from the data.LAMININ-2 IN THYMOCYTE DEVELOPMENT 183
Analysis of Apoptosis in situ
Tissue sections (3 tm) were analyzed for apoptosis by
TUNEL (TdT-mediated dUTP Nick End Labeling)
staining. These analyses were conducted by Chesa-
peake Histology Labs, Inc., Baltimore, MD according
to the method of Brown et al (Brown et al, 1996).
Results
Quantitation of Thymocytes in Dystrophic Mice
The dy/dy mice display classic muscular dystrophy
symptoms including muscle weakness and impaired
motor abilities. The dy/dy mice are apparent from
their inability to fight when held by their tails, splayed
limbs, difficulty of movement, small body size and
lack of muscle mass, relative to heterozygous and
wildtype littermates. The differences in body and
organ size between dy/dy mice and their normal (dy/+
and +/+) littermates were quantitated for the purposes
of comparison and control within our analyses (Table
I). In this set of data, the decreased size of the dy/dy
mice is apparent, as is the diminished mass of their
thymi. Thymus weight alnd the number of thymocytes
recovered from each thymus are standardized to body
mass and thymus mass respectively to demonstrate
that the thymus is reduced in size and cell numbers
even relative to the reduced body size of these mice,
i.e. the loss of thymocytes is out of proportion with
the size of the mice. Interestingly, in the
C57BL/6J-dy2J mice, which display neuromuscular
symptoms comparable to the dy/dy mice, the size of
the thymus and the number of thymocytes recovered
were similar to the dy control littermates (data not
shown). These results indicate that expression of lam-
inin-2 is required for normal thymic development and
that the N-terminal truncated laminin-2 expressed by
the dy2J mice is sufficient to provide for normal
development.
Analysis ofDystrophic Thymic Architecture
Having observed the dramatically decreased mass of
the thymus and the loss of thymocytes in the dy/dy
mice, histological analyses were carried out to exam-
ine the structure of the thymus, its component cell
types and the expression of extracellular matrix com-
ponents in the thymus.
To examine the dy/dy thymic architecture, hemo-
toxylin-eosin (H&E) stainings were performed. Com-
parison of H&E staining of the dy/dy thymus with a
control littermate thymus showed not only the
decreased size of the dystrophic thymus, but also the
abnormal thymocyte distribution within the dys-
trophic thymus (Fig. 1A). The difference in size
between the dy/dy and dy control thymi is apparent in
this figure where, at the same magnification, the dy
control photomicrograph shows a portion of a thymus
while the dy/dy photomicrograph shows an entire thy-
mus. The cortical and medullary regions of the dy/dy
thymus cannot be distinguished by H&E staining. The
cell density throughout the dy/dy thymus is compara-
ble to the cell density in the medullary region of the
dy control thymus (Fig. 1A). This apparent diminu-
tion of the cortex may be explained by destruction of
thymic epithelium or by loss of cortical thymocytes.
To examine the distribution of thymic epithelial cell
types, thymic sections were stained with antibodies
specific for cortical or medullary epithelia. Figure 1B
shows the staining pattern with the ERTR5 anti-medul-
lary epithelium and Figure 1C shows the staining with
4F1 anti-cortical epithelium antibodies. It is apparent
from these stainings that the cortical and medullary
epithelia are present in the dy/dy thymi. Therefore, the
apparent loss of the cortex in these mice must mainly
result from a diminution in cortical thymocytes.
These thymic sections were also analyzed for
expression of the laminin chains which are common to
both laminin-1 and laminin-2. Figure 1D shows the
immunofluorescent staining pattern obtained with the
Clone I antibody which is specific for the laminin 1
and ,1 chains. Expression of the laminin [1 and ,1
chains can be detected in both thymic cortical and med-
ullary regions from dy control mice. It is clear that
expression of these chains is lost in the dy/dy thymi.
Flow Cytometric Analysis ofThymocyte Populations
in Dystrophic Mice
Since it appeared that the dy/dy mice demonstrated a
lack of cortical thymocytes, we performed a variety of184 WILLIAM J. MAGNER et al.
FIGURE Immunohistochemical analyses of dy/dy and dy control thymi. Panel A is shown at 25X magnification, panels B-E are 50X. A
Hemotoxilin-Eosin staining of thymic sections were performed to reveal the intact thymic architecture. As stated in Table I, the dy/dy thymi
are much smaller and contained fewer cells than those of control littermates. The cortex (C) and medulla (M) are clearly visible in the dy con-
trol but not in the dy/dy thymus. B & C. Immunohistochemical staining for cortical and medullary epitopes. To characterize the thymic archi-
tecture, thymic sections were stained with antibodies specific for cortical or medullary epithelia (4F1 and ERTR5 respectively). The cortical
and medullary epithelia are clearly present but smaller or more compact in the dy/dy mice. D. Immunohistochemical staining for laminin [
and y1 chains. To examine laminin expression, thymic sections were stained with the Clone antibody which is specific for the laminin
and y1 chains; these chains are common to laminin-1 and laminin-2. The dy/dy thymus is clearly deficient in laminin 1 and y1 protein
expression. The antibody used is IgM, the high background appeared to be characteristic of this antibody. Despite the high background, the
classic ECM network staining is not visible in the dy/dy section. E. Isotype matched negative control for Figure 1D (see Color Plate XII at
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flow cytometric analyses to examine discrete popula-
tions of developing thymocytes. Unfractionated adult
thymocytes were stained for two-color flow cytome-
try with anti-CD4 and anti-CD8 antibodies for analy-
sis of double negative, double positive and single
positive populations. A representative plot of
CD4/CD8 analysis is shown in Figure 2A. The propor-
tion of all populations was significantly larger in the
dy/dy mice except for the DP thymocyte population
which was significantly smaller (83 % vs. 33 %). The
four-fold increase in mature thymocytes (CD4+CD8-,
CD4-CD8+) in dy/dy mice relative to control mice
(44% vs 12% of total thymocytes) (Fig. 2A) may, at
least partially, explain the diminished cortical regions
of dy/dy mice. All of the thymocyte populations exam-
ined in the dy2Jmice were comparable to wild type
C57BL/6J as a percentage of total thymocytes and
absolute cell numbers (CD4/CD8 analysis is shown in
Figure 2A). These results suggest that the loss of thy-
mocyte populations observed in the dy/dy mice was
specific to the lack of laminin-2 in their thymi, was not
a secondary effect of their physical condition since dy2J
mice, which display neuromuscular symptoms compa-
rable to the dy/dy mice, had normal thymocyte popula-
tions, and was not dependent on the N-terminus of the
laminin2 chain.
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FIGURE 2 Flow cytometric analyses of dystrophic and control thymocytes. To characterize thymocyte populations, thymocytes isolated
from dystrophic and control mice were stained with antibodies to thymic subset markers and analyzed by flow cytometry. The quadrant per-
centages are shown within each quadrant. These plots clearly show significant loss of cells from the CD4+CD8+and CD4-CD8-CD44-CD25
populations in the dy/dy mice. A. Bulk thymocytes from dy/dy and dy control and dy2J mice were stained with PE-anti-CD4 and
FITC-anti-CD8. Maturation progresses from CD4- CD8- to CD4+CD8 to CD4+CD8 or CD4-CD8 B. DN thymocytes were prepared from
dy/dy and dy control animals and stained with PE-anti-CD44 and FITC-anti-CD25. Maturation progresses from CD44+CD25 to
CD44+CD25 to CD44-CD25 to CD44-CD25-186 WILLIAM J. MAGNER et al.
The fact that the least mature CD4/CD8 (DN) thy-
mocyte subpopulation showed such a dramatic pro-
portional increase in dy/dy versus dy control mice
(23% vs 5%) led us to examine whether developmen-
tal defects could be detected in this population. To
examine early thymocyte development in dy/dy mice,
adult thymocytes were fractionated and the double
negative population was recovered. These cells were
stained with anti-CD44 and anti-CD25 antibodies for
analysis of the developing early thymocyte popula-
tions. The most immature thymocytes examined
(Figure 2B) are the CD44+CD25 population. A dimi-
nution of this population could indicate a defect in the
ability of thymocyte progenitors to home to the thy-
mus (Ruiz et al, 1995). In this case however, the rela-
tively large number of DN CD44+CD25 thymocytes
in dy/dy mice makes a homing defect unlikely but,
instead, the relative four-fold increase of this popula-
tion in dy/dy mice as compared to dy control mice
(59% vs 13%), makes it more likely that many of the
immature thymocytes fail to receive a proper differen-
tiation signal. Once escaping this stage of differentia-
tion, development appears to proceed normally as the
ratio of cells in the progressively more mature
CD44+CD25+, CD44;CD25+, CD44-CD25-cell com-
partments is about the same for dy/dy and dy control
mice. These studies indicate that, in dy/dy mice, cells
tend to accumulate within the most immature thymo-
cyte subpopulation indicating that many fail to
receive a signal necessary for differentiation. Whether
all immature thymocytes require this differentiation
signal and/or whether the cells that do differentiate do
so normally are questions for examination.
Ability ofdy/dy Thymocytes to Adhere to Laminin-2
Since thymocytes of dy/dy mice develop in the
absence of laminin-2, we wanted to determine
whether these thymocytes maintain their ability to
bind to laminin-2 or whether the thymocytes present
in the dy/dy mice develop from a population which
can not adhere to laminin-2.
To measure the ability of dy/dy thymocytes to
adhere to laminin-2 relative to thymocytes from wild
type control mice, adhesion assays were performed on
purified ECM proteins. Unfractionated thymocytes
from dy/dy, dy control and dy2J mice were assayed for
adhesion to laminin-2 and to fibronectin (Figure 3).
When the wells were coated with fibronectin, thymo-
cytes from all three mouse strains behaved equiva-
lently, each displaying comparable, saturable binding
with a maximum of approximately 15% of cells
bound. When the wells were coated with laminin-2,
dy/dy thymocytes bound best and thymocytes from
the dy control mice displayed the weakest binding at
every ECM concentration tested. We can only con-
clude with confidence that all three strains are capable
of binding laminin-2 and that dy/dy thymocytes retain
the ability to bind laminin-2. We have previously
shown (Chang et al, 1993), through antibody treat-
ment of thymocytes before the adhesion assay, that
thymocyte binding to laminin-2 is VLA-6 dependent
and binding to fibronectin is dependent upon VLA-4
and 5. The enhanced binding dy/dy thymocytes dis-
play toward laminin-2 is not unexpected flow cyto-
metric analyses demonstrated that VLA-6 expression
was increased on these cells (data not shown). It is
possible that thymocyte adhesion to laminin-2 leads
to downregulation of VLA-6. Adhesion to laminin-2
would provide a needed co-stimulatory or survival
signal followed by VLA-6 downregulation and con-
tinued migration and development. These possibilities
will be the subjects of future studies.
Analysis ofApoptosis in Dystrophic Thymi
The decreased cell numbers in dy/dy thymi could
result from a lack of proliferation or from an
increased death of early thymocytes. Apoptosis is a
very active process in the thymus. The majority of
developing thymocytes die during selection and never
reach the periphery. To examine apoptosis in the dy
mice, fixed thymi were sectioned and stained by the
TUNEL method. As shown in Figure 4, the dy/dy thy-
mus contains a significantly increased number of
apoptotic cells relative to the dy control section.
These apoptotic thymocytes were found in the capsu-
lar and subcapsular regions where DN thymocytes
reside. The dy2J mice were also analyzed for thymic
apoptosis. As seen in Figure 4, the dy2J thymi appear
quite normal and do not display the increased apopto-
sis seen in the dy/dy thymi. Thus, the lack of lam-LAMININ-2 IN THYMOCYTE DEVELOPMENT 187
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FIGURE 3 Thymocyte adhesion to ECM proteins. To analyze the ability of thymocytes from dy/dy, dy2J and dy control animals to bind to
specific ECM proteins, adhesion assays were conducted on laminin-2 and fibronectin. The assays shown in this figure were conducted with a
concentration (20 tg/ml ECM protein) used to coat the wells of the plates which provided maximal binding on each substrate
inin-2 expression in dy/dy mice appears to result in an
increased level of apoptotic cell death among early
thymocytes which is not seen in dy2J dystrophic mice.
To identify the specific immature thymocyte popu-
lation(s) which undergo enhanced apoptosis in dy/dy
mice, flow cytoenzymology was applied in conjunc-
tion with flow cytometry. This technique allowed
fresh thymocytes, surface labeled for flow cytometry,
to be loaded with a substrate specific for an individual
enzyme expected to be active in the apoptotic cascade
(Porter and Janicke, 1999, Berliner et al, 1997).
Cleavage of the substrates used in this analysis by
their specific caspase enzymes, releases fluorescent
molecules which are observed and quantitated via
standard flow cytometry. Figure 5A illustrates the flu-
orescent shifts which can be achieved with this tech-
nique and serves at a control from which bounds are
defined for quantitation of apoptotic cells. Through
this technique, we were able to detect elevated apop-
tosis throughout the immature dy/dy thymic subpopu-
lations but primarily among the CD25+ DN
thymocyte populations (Figure 5B).
The in situ TUNEL assay and flow cytoenzymol-
ogy technique provided mutually supportive evidence188 WILLIAM J. MAGNER et al.
Apoptosis analysis by TUNEL staining
dy cont dy/dy dy 2J
FIGURE 4 Histochemical analysis for apoptotic cells. To analyze apoptotic cell death in dystrophic mice, the TUNEL staining technique was
applied to sections of thymi from dystrophic and control mice. The subcapsular region of the dy/dy thymus clearly contains significantly
more apoptotic cells than the section from its control littermate. This supports our hypothesis of increased apoptotic death in an early thy-
mocyte population. TUNEL staining of the dy2J thymi and their wildtype controls did not show any visible difference in apoptosis in the dy2J
(see Color Plate XIII at the back of this issue)
that the CD4-CD8- early thymocytes of dy/dy mice
undergo a high level of apoptotic cell death. These
data provide an explanation for the loss of immature
thymocytes (apoptotic death) and of CD4+CD8+ thy-
mocytes (death of their precursor population) seen in
our FACS analyses of dy/dy mice.
DISCUSSION
We previously showed that laminin-2, and not lam-
inn-1, is expressed in the thymus and that a portion of
thymocytes can adhere to laminin-2 (Chang et al,
1993). We also demonstrated that immobilized lam-
inin-2 provides a co-stimulatory signal for
anti-CD3-induced human thymocyte proliferation
(Chang et al, 1995) These observations led to our pro-
posal that laminin-2 plays a specific role in the devel-
opment of thymocytes. Thus, we have used the
laminin-2 deficient dy mouse as a model system in
which to examine this hypothesis.
The thymi of these dystrophic mice are dispropor-
tionately reduced in mass when compared to their
control littermates. The number of thymocytes which
can be isolated from these thymi is also reduced out
of proportion with the size of the thymus. Phenotypic
analysis of these thymocytes for CD4 and CD8
expression showed that the proportion of DN cells
was dramatically increased in dy/dy mice along with a
concomitant decease in DP cells. This suggested that
many immature (DN) thymocytes were failing to
develop properly. Examination of the CD4-CD8- pop-
ulation for expression of the CD44 and CD25 devel-
opmental markers revealed a large proportional
increase in the most immature thymocyte population
(CD44+CD25-) in dy/dy mice (Fig. 2B). Thus, at the
earliest stage of maturation, many dy/dy thymocytes
fail to receive a signal necessary for differentiation.
In order to determine if the failure to receive the
appropriate differentiation signal led to cell death, the
thymi from the dystrophic mice and their controls
were examined for apoptotic cells (Fig. 4). An
increase in apoptotic thymocytes was found in the
dy/dy mice primarily in the capsular and subcapsular
regions where immature thymocytes are known to
localize, We next examined each of the four subpopu-
lations of DN thymocytes, as defined by CD44 and
CD25 expression, for apoptosis using a flow cytomet-LAMININ-2 IN THYMOCYTE DEVELOPMENT 189
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FIGURE 5 Combined flow cytometry and flow cytoenzymology define apoptotic thymocyte populations. To characterize apoptotic thy-
mocyte populations, thymocytes isolated from dystrophic and control mice were stained with antibodies to thymic subset markers and ana-
lyzed by flow cytometry and flow cytoenzymology. The DEVD-Caspase 3 substrate (Coulter Corp.) releases a fluorophore readable on FL1
when the substrate is cleaved by caspase 3. Cell viability and surface markers were analyzed on FL2, FL3, and FL4 by typical flow cytomet-
ric techniques. A. This flow cytoenzymology histogram demonstrates the fluorescence shifts which can be obtained with this substrate. The
solid peak to the left represents autofluorescence of cells loaded with substrate but not subjected to apoptotic stimulation. The peak to the
right was obtained from cells stimulated with crosslinked anti-Fas antibodies 3 hours prior to exposure to substrate. This control was used to
set markers by which to define the percent of apoptotic cells. B. DN thymocytes were prepared from dy/dy and dy control mice and stained
with PE-anti-CD44 and biotinyl-anti-CD25 plus streptavidin-APC to obtain profiles (FL2 vs FL4) similar to Figure 2B. The subpopulations
were then analyzed for caspase activity in FL1. The histograms shown here display dy contol profiles in filled peaks with dy/dy profiles over-
laid. The percent of cells shifted into the apoptotic markers is noted in each panel190 WILLIAM J. MAGNER et al.
ric assay. Each of the populations exhibited a signifi-
cant increase in apoptotic cells relative to control
thymocytes. This indicates that, at each stage of dif-
ferentiation in the DN compartment of the thymus,
laminin-2 is required for survival of the majority of
cells or that failure to receive a laminin-2 survival sig-
nal early in differentiation programs thymocytes for
death.
To determine the stage of development at which
laminin-2 plays it’s critical role, we examined thymo-
cyte profiles from fetal day 16 through neonatal day
14. Thymocytes from these animals were analyzed by
FACS for CD4, CD8, CD25 and CD44 expression
while other tissues were analyzed by PCR for geno-
type and gender determination (data not shown). In
the ages analyzed, we did not observe any significant
perturbation of thymocyte subsets. It appears that
laminin-2 is required for normal thymocyte develop-
ment as mice reach young adulthood (2-4 weeks of
age).
We examined the B cell, NK cell andT T cell pop-
ulations by flow cytometry, taking advantage of a
variety of cell surface markers, but did not find any
perturbation of any of these populations. Thus, in the
immune system, the cevelopmental effects of the lack
of laminin-2 appear to be restricted to specific early
x[3 T cell progenitors.
We used several strategies to test the function of
positive and negative selection in these mice (data not
shown). Immunoglobulin class switching occurred
normally in the dy/dy mice and their response to oval-
bumin was not different from control littermates. Our
examinations of the T cell receptor repertoires and
primary responses of thymocytes and Ia-splenocytes
have not revealed any alterations in the dy/dy mice.
Therefore, we have concluded that both positive and
negative selection appear to be functioning normally
in these mice. The loss of thymocytes of specific
types without a gross disruption of mature T cell rep-
ertoire or response may be taken as an indication that
the developmental role of laminin-2 is related to pro-
liferation or survival without affecting T cell differen-
tation (Guidos, 1996). The ratio of DP to SP
thymocytes in dy/dy mice relative to dy control mice
suggests that there may be alterations in selection,
proliferation or emigration which were not detected
by our assays. These intriguing possibilities can be
investigated through breeding with TCR transgenic
strains and will be the subject of future studies.
To assess the ability of dy/dy thymocytes to prolif-
erate, thymocytes and Ia- splenocytes from dy/dy and
dy control mice were compared in standard tritium
incorporation assays with anti-TCR stimulation with
and without co-stimulation by laminin-2, In each
case, the mutant and wild type thymocytes gave indis-
tinguishable levels of proliferation (data not shown).
The lack of laminin-2 during development does not
affect the proliferation of the populations tested.
We propose a model of thymocyte development
(Figure 6, model 1) in which laminin-2 provides a
survival signal to early thymocytes in the subcapsular
region of the thymus. In the absence of this signal,
thymocytes enter apoptosis while, in the presence of
laminin-2, these cells are able to undergo differentia-
tion and proliferation and further populate the thy-
mus. Early in thymocyte development, when the cells
are undergoing a rapid expansion, laminin-2 provides
a signal for the developing thymocytes to survive and
maintain their proliferative state. In mice lacking lam-
inin-2, these cells instead revert to an apoptotic death
program and a major portion of the thymocytes do not
survive to populate the thymus. The dramatic increase
in apoptosis evident in the capsule and subcapsular
regions of the dy/dy thymi appears sufficient to
explain the overall decrease in the number of thymo-
cytes by showing that most cells in the immature thy-
mocyte population are in the process of dying. This
would result in fewer thymocytes entering the DP
population which would explain why cortical regions
are not readily defined by H&E staining despite the
presence of cortical epithelium.
An alternative model (Figure 6, model 2) would
have laminin-2 deliver a proliferative signal to early
thymocytes. In the case of the dy/dy mice, this signal
would be lacking and thymocytes would proceed to
develop and migrate but would not proliferate. This
model would explain the diminished thymocyte num-
bers in all of the CD4/CD8 thymic populations but
does not readily explain the decrease of specific pop-LAMININ-2 IN THYMOCYTE DEVELOPMENT 191
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FIGURE 6 Models to explain the effect of the dy mutation on thymocyte development. Model we propose that laminin-2 provides a sur-
vival signal needed by thymocytes at specific developmental checkpoints in their early maturation. The absence of this signal results in
increased cell death early in development and thus a lack of cells moving along the thymic maturation pathway. Specific populations which
have a more stringent requirement for this signal may then be underrepresented relative to other populations. Lack of a survival signal would
be predicted to lead to an increase in programmed cell death among the populations which require the signal. Model 2 alternatively, we
propose that laminin-2 could provide a proliferative signal to the developing thymocytes. The loss of this signal would diminish the number
of cells progressing along the route to maturation. This model would affect overall cell number and could result in underrepresentation of
specific populations in which this proliferative signal was required. This model would not predict an alteration in programmed cell death
ulations. This model would also not explain an
increase in apoptotic death of immature thymocytes.
We cannot differentiate between the specific sur-
vival signal described in our first model and the possi-
bility that laminin-2 may be required to direct or
stabilize thymocytes to receive positive selection sig-
nals. In such a case, the lack of laminin-2 could result
in "death by neglect" for the majority of thymocytes.
For this reason, these two possibilities are considered
indistinguishable and both covered by this model In
support of the concept of a specific survival signal,
Vachon et al (Vachon et al, 1996) describe the role of
merosin (laminin-2) in myogenesis as "to promote
myotube stability by preventing apoptosis". In many
ways, the increased apoptosis seen in the myogenesis
system and the protective effect of merosin parallel
our results with thymocytes from laminin-2 deficient
mice.
Our study of the dy2J mice indicates that their spe-
cific mutation in laminin-2 produced comparable
physical symptoms without the concomitant loss of
thymocytes. Our analyses of the dy2J mice support
our conclusions from studying the dy/dy mice by
demonstrating that the thymocyte loss does not corre-
late with the disease the two strains show compara-
ble physical symptoms but the thymic effects are only192 WILLIAM J. MAGNER et al.
found in the strain which does not express laminin-2.
It is also apparent from this result that the N terminal
region of the o2 chain of laminin is not critical for
laminin-2 function in the thymus but it is critical in
muscle. This can be explained by our hypothesis of
the role of VLA-6 in the thymus and the reported role
of cz-dystroglycan in muscle.
Our in vitro studies of thymocyte binding to lam-
inin-2 demonstrated that the cellular receptor for lam-
inin-2 was the integrin VLA-6 (o6131) (Chang et al,
1993). Studies of the dystrophin-associated glycopro-
tein complex in muscle showed that its component
cz-dystroglycan was the laminin-2 binding protein
(Worton, 1995). Since the defect in dy2J mice, which
leads to muscular dystrophy symptoms, has been
mapped as an N-terminal laminin (z2 deletion, and yet
thymocytes from these mice undergo normal develop-
ment, we can conclude that the cz-dystroglycan bind-
ing site and the 61 binding site are distinct. This
agrees with a previous study (Deutzmann et al, 1990)
in which the 06 binding site was mapped to a
region outside of the N terminal segment deleted in
the dy2J mice.
The dystrophic mice have provided an in vivo sys-
tem in which to directly examine the effects of the
loss of a specific extracellular matrix protein. Our ear-
lier hypothesis (Chang et al, 1993) of a role for lam-
inin-2 and VLA-6 in thymocyte development has now
been demonstrated directly and this function has been
specifically identified as a mediator of cell survival
(Giancotti, 1997, Meredith et al, 1993). This extracel-
lular matrix protein thus is delivering a specific signal
to a select population of cells at a critical point in their
development. The lack of this signal then results in
the activation of a default programmed cell death
pathway. The resultant apoptosis causes a diminution
of the immature thymocytes available to progress
through development, maturation and selection lead-
ing to fewer thymocytes and T cells to populate the
animal.
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